-
Mashup Score: 1Likelihood of COVID-19 Outbreaks in US Immigration and Customs Enforcement (ICE) Detention Centers, 2020‒2021 | AJPH | Vol. Issue - 5 month(s) ago
Objectives. To determine facility-level factors associated with COVID-19 outbreaks in US Immigration and Customs Enforcement (ICE) detention centers. Methods. We obtained COVID-19 case counts at 88 ICE detention facilities from May 6, 2020, through June 21, 2021, from the COVID Prison Project. We obtained information about facility population size, facility type (dedicated to immigrants or mixed with other incarcerated populations), and facility operator (public vs private contractor) from third-party sources. We defined the threshold for a COVID-19 outbreak as a cumulative 3-week incidence of 10% or more of the detained population. Results. Sixty-three facilities (72%) had at least 1 outbreak. Facilities with any outbreak were significantly more likely to be privately operated (P < .001), to have larger populations (113 vs 37; P = .002), and to have greater changes in their population size over the study period (‒56% vs −26%; P < .001). Conclusions. Several facility-level factors were
Source: ajph.aphapublications.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection - 7 month(s) ago
Even when successfully induced, immunological tolerance to solid organs remains vulnerable to inflammatory insults, which can trigger rejection. In a mouse model of cardiac allograft tolerance in which infection with Listeria monocytogenes (Lm) precipitates …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
RT @StanfordMedRes: Check out PGY-1 @C_M_McIntosh's latest publication! #ResidentResearch https://t.co/l4iM0hWcfk Additional shoutout t…
-
-
Mashup Score: 0
BACKGROUND: Anthracycline-induced cardiotoxicity has a variable incidence, and the development of left ventricular dysfunction is preceded by elevations in cardiac troponin concentrations. Beta-adren
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet-
🤔 Great work by @ninianlang & colleagues - once again calling into question the role of troponin monitoring & “cardioprotective cardiac meds” in #anthracycline Rx. The almost unbelievable 🇮🇹 data from 2000s remains a BIG outlier... #CardioOnc https://t.co/70iemfjk6X
-
-
Mashup Score: 1Development and validation of a rapid visual technique for left ventricular hypertrophy detection from the electrocardiogram - 1 year(s) ago
IntroductionLeft ventricular hypertrophy (LVH) detection techniques on by electrocardiogram (ECG) are cumbersome to remember with modest performance. This study validated a rapid technique for LVH detection and measured its performance against other techniques.MethodsThis was a retrospective cohort study of patients at Stanford Health Care who received ECGs and resting transthoracic echocardiograms (TTE) from 2006 through 2018. The novel technique, Witteles-Somani (WS), assesses for S- and R-wave overlap on adjacent precordial leads. The WS, Sokolow-Lyon, Cornell, and Peguero-Lo Presti techniques were algorithmically implemented on ECGs. Classification metrics, receiver-operator curves, and Pearson correlations measured performance. Age- and sex-adjusted Cox proportional hazard models evaluated associations between incident cardiovascular outcomes and each technique.ResultsA total of 53,333 ECG-TTE pairs from 18,873 patients were identified. Of all ECG-TTE pairs, 21,638 (40.6%) had TTE
Source: www.frontiersin.orgCategories: Cardiologists, Latest HeadlinesTweet-
(2/2) Sulaiman took a joke I routinely made during @StanfordDeptMed #CCU rounds about the “Witteles criteria” for detecting LVH and actually rigorously tested and proved it. INCREDIBLE! For those interested, just published here: https://t.co/JeyjzUvgI5
-
-
Mashup Score: 2The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer: - 1 year(s) ago
Abstract Background Sodium glucose cotransporter-2 inhibitors (SGLT2is) are hypothesized to reduce the risk of anthracycline-associated cardiotoxicity. Objectives This study sought to determine the…
Source: www.jacc.orgCategories: Cardiologists, Latest HeadlinesTweet-
Really nice thought-provoking work by @dineshpmcc1 & colleagues in @JACCJournals:#CardioOnc examining #SGLT2 inhibitors & cardioprotection in #anthracycline treated patients. 🤔Good rationale for randomized trials. Congrats! https://t.co/T40J1W9YdU https://t.co/5yNtd0iT2S
-
-
Mashup Score: 0
BACKGROUND: AL amyloidosis is a rare, progressive, and typically fatal disease caused by both soluble and insoluble (amyloid) forms of misfolded immunoglobulin
Source: American Society of HematologyCategories: Cardiologists, Latest HeadlinesTweet-
(3/9) Prior anti-amyloid studies have shown promise in early trials but have failed in later stages, most recently with NEOD001 targeted at AL amyloidosis. https://t.co/z8TfIbFKsN
-
-
Mashup Score: 5
This qualitative study evaluates user-generated, publicly available posts and comments about statin-related topics: ketogenic diets, diabetes, and supplements; statin adverse effects; statin hesitancy; clinical trial appraisals; pharmaceutical industry bias; and red yeast rice.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Incredible work by super⭐️ @StanfordMedRes PGY-2 #SulaimanSomani on this piece in @JAMANetworkOpen on #AI and #statins. Congratulations!!! @FaRodriguezMD @AshishSarraju @HeartBobH @StanfordDeptMed @StanfordChiefs @JAMANetwork https://t.co/YVXvNy4GLC
-
-
Mashup Score: 12Atorvastatin Cut Anthracycline Cardiac Dysfunction - 2 year(s) ago
A daily 40-mg dose of atorvastatin for 12 months significantly cut incident cardiac dysfunction in patients with lymphoma receiving anthracycline treatment.
Source: MedscapeCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Ron_Witteles: Nice article from @medscape covering the STOP-CA trial from #ACC23. https://t.co/5x8bkSbgbQ @TomasNeilan @AnaBaracCardio…
-
Nice article from @medscape covering the STOP-CA trial from #ACC23. https://t.co/5x8bkSbgbQ @TomasNeilan @AnaBaracCardio @gmelendezMD @HanZhuMD @Paul_P_Cheng @JuneWRhee @JJheart_doc @SWaliany @ninianlang @CardioOncology @Dr_Mike_Fradley @SeanM_Wu #CardioOnc
-
-
Mashup Score: 4Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines - 2 year(s) ago
The concerns range from low levels of evidence for some recommendations to issues of implementation and overreach.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Nice article in @TCTMD on the @escardio #CardioOnc guidelines, highlighting the recent perspectives in @JACCJournals #JACC:CardioOnc. The guidelines are a true triumph, but with some very important words of caution… ⚠️⚠️⚠️ https://t.co/u4oLNW2OLY
-
-
Mashup Score: 6
IntroductionIt is difficult to assign a precise date to the birth of the field of cardio-oncology. Although cardiac effects of anthracyclines have been known for decades, the field as we now know it truly emerged in the early to mid-2000s, largely in response to recognized cardiac toxicities from trastuzumab and vascular endothelial growth factor (VEGF) inhibitors. Since that time, the field has…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
Proud of the series of editorials on the @escardio #CardioOncology guidelines just published in @JACCJournals JACC:CardioOncology. Link attached for ours. The guidelines are a TRUE triumph - but with a major caution⚠️around promoting overscreening. https://t.co/1rawReIb41
-
RT @ec_woods: I'm excited to share another research paper that came out of my time in residency: https://t.co/CcNPXXxA3c Grateful to my men…